Clinical Trials Arena

News, views and contacts from the global Clinical industry
17 January 2019
DAILY UPDATE
Industry News

Cancer patients with comorbid conditions less likely to enrol in trials
Cancer patients with comorbid disorders are less likely to be offered the opportunity to take part in a clinical trial, according to a study published in JAMA Oncology

EMA publishes revised guidelines on antibacterial drug development
The European Medicines Agency (EMA) has published revised guidelines on the development and evaluation of human medicines intended to treat bacterial infections.

The Top 10: 2018
Clinical Trials Arena highlights the best articles from 2018

Industry Viewpoints: Choosing the Right CRO
In this Industry Viewpoint, CTA’s Elizabeth Williams speaks with Philip Arlen to discuss key considerations when formulating an outsourcing strategy

Press Releases

Forty-three Countries Across Five Continents – A Global Pharmacovigilance Company

IntuVigilance win major Pharma Industry Award

Product Selection
There are several forces pushing healthcare professionals to provide patients with personalized medicine, in which treatments are tailored to suit the needs of individual patients.

Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany
New site will support complex clinical research and bring more than 200 new jobs to community

Thermo Fisher Scientific Completes Acquisition of Patheon
WALTHAM, Mass., Aug. 29, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has completed its acquisition of Patheon N.V. (NYSE: PTHN), a leading contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. Today's close follows the expiration of Thermo Fisher's initial tender offer for Patheon at $35.00 per share in cash.

White Papers

Building The Industry’s Most Advanced Modeling Engine
For the past ten years, the industry has seen an increased demand to determine fair market value of CRO and other clinical trial service providers.

Clinical Trials: Enrollment Trends in Emerging Markets – Russia
Scotty Chung-Siu, Brooke Wilson & Revati Tatake, GlobalData, examine developments in the Russian clinical trial space

Clinical Trials: Enrollment Trends in Emerging Markets – Brazil
In an exclusive white paper, Brooke Wilson, Revati Tatake & Bonnie Bain, GlobalData, assess the clinical trial landscape in Brazil

Clinical Trials: Enrollment Trends in Emerging Markets – South Korea
This whitepaper provides a review of Phase I to Phase IV clinical trials with a start date between January 1, 2001 and June 5, 2018, and which have a trial location in South Korea.

Clinical Trials: Enrollment Trends in Emerging Markets – India
This whitepaper provides a review of the enrollment trends of Phase I to Phase IV clinical trials that had a start date between January 1, 2001 and December 31, 2018 and a trial location in India.

Follow Us:   Facebook Facebook    Twitter Twitter    LinkedIn LinkedIn    YouTube YouTube   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Clinical Trials Arena or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

www.clinicaltrialsarena.com is a product of Kable.
Copyright
2019 Kable, a trading division of Kable Intelligence Limited.